Clinical Research Network Services for Resistance

The government authority located in Washington, DC, requires a vendor to provide clinical research network services for resistance. The buyer needs the Clinical Research Network to advance clinical research, including trials, studies, and related activities that enhance the prevention, diagnosis, and treatment of urgent healthcare-associated, bloodstream, urinary tract, and respiratory infections. Under the scope of work, the vendor will conduct strategy trials to optimize the use of currently licensed antimicrobials, investigate diagnostic tests that refine treatment strategies, and support regulatory approval of new diagnostic tests. The buyer restricts eligibility to USA organizations only and requires onsite performance of the work. The buyer seeks proposals to determine the budget for this procurement. The provided text contains no specific evaluation criteria or key dates.